Economic considerations of prostate cancer. The role of detection specificity and biopsy reduction
- 1 April 1995
- Vol. 75 (S7) , 1987-1993
- https://doi.org/10.1002/1097-0142(19950401)75:7+<1987::aid-cncr2820751639>3.0.co;2-0
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Cost-effective prostate cancer detection. Reduction of low-yield biopsiesCancer, 1994
- Cost Analyses of Prostate Cancer Screening: Frameworks For DiscussionJournal of Urology, 1994
- Screening for Prostate CancerPublished by American Medical Association (AMA) ,1994
- Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA changeCancer, 1994
- Results of Conservative Management of Clinically Localized Prostate CancerNew England Journal of Medicine, 1994
- An Assessment of Radical ProstatectomyJAMA, 1993
- A Decision Analysis of Alternative Treatment Strategies for Clinically Localized Prostate CancerPublished by American Medical Association (AMA) ,1993
- A structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research TeamArchives of Family Medicine, 1993
- Serum Prostate Specific Antigen as Pre-Screening Test for Prostate CancerJournal of Urology, 1992
- In Search of Methuselah: Estimating the Upper Limits to Human LongevityScience, 1990